ArticlePolymers2025
Molded Part Warpage Optimization Using Inverse Contouring Method.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-objective optimization of dimensional accuracy and part weight in injection molding of a 3D curved shin guard plate.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Warpage is among the most prevalent defects affecting injection molded parts. In this study, we aimed to develop methods to minimize warpage through mold design. Common strategies include matching the cavity geometry to the intended shape of the part, adjusting cavity dimensions to offset material shrinkage, and optimizing the cooling system and critical injection molding parameters. These optimization methods can offer significant improvements, but recently introduced methods that optimize the molded part and mold cavity shape result in higher levels of warpage reduction. In these methods, optimization of the shape of the molded part is achieved by shaping it in the opposite direction of warpage-a method known as inverse contouring. Inverse contouring of molded parts is a design technique in which mold cavities are intentionally modified to incorporate compensatory geometric deviations in regions anticipated to exhibit significant warpage. The final result after molded part ejection and warpage is a significant reduction in deviations between the warped and reference molded part geometries. In this study, a two-step approach for minimizing warpage was used: the first step was optimizing the most significant injection molding parameters, and the second was inverse contouring. In the first step, Response Surface Methodology (RSM) and Autodesk Moldflow Insight 2023 simulations were used to optimize molded part warpage based on three processing parameters: melt temperature, target mold temperature, and coolant temperature. For improved accuracy, a Computer-Aided Design (CAD) model of the warped molded part was exported into ZEISS Inspect 2023 software and aligned with the reference CAD geometry of the molded part. The maximal warpage value after the initial simulation was 1.85 mm based on Autodesk Moldflow Insight simulations and 1.67 mm based on ZEISS Inspect alignment. After RSM optimization, the maximal warpage was 0.73 mm. In the second step, inverse contouring was performed on the molded part, utilizing the initial injection molding simulation results to further reduce warpage. In this step, the CAD model of the redesigned, inverse-contoured molded part was imported into Moldflow Insight to conduct a second iteration of the injection molding simulation. The simulation results were exported into ZEISS Inspect software for a final analysis and comparison with the reference CAD model. The warpage values after inverse contouring were reduced within the range of ±0.30 mm, which represents a significant decrease in warpage of approximately 82%. Both steps are presented in a case study on an injection molded part made of polybutylene terephthalate (PBT) with 30% glass fiber (GF).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.